Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cabot (CBT) Research & Development (2016 - 2025)

Cabot (CBT) has disclosed Research & Development for 17 consecutive years, with $13.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 7.14% to $13.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.0 million through Dec 2025, down 6.45% year-over-year, with the annual reading at $59.0 million for FY2025, 6.35% down from the prior year.
  • Research & Development for Q4 2025 was $13.0 million at Cabot, down from $15.0 million in the prior quarter.
  • The five-year high for Research & Development was $17.0 million in Q3 2024, with the low at $12.0 million in Q2 2021.
  • Average Research & Development over 5 years is $14.4 million, with a median of $15.0 million recorded in 2021.
  • The sharpest move saw Research & Development rose 21.43% in 2024, then fell 11.76% in 2025.
  • Over 5 years, Research & Development stood at $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then grew by 15.38% to $15.0 million in 2023, then dropped by 6.67% to $14.0 million in 2024, then decreased by 7.14% to $13.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $13.0 million, $15.0 million, and $15.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.